Emory University’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-149,013
Closed -$1.41M 52
2018
Q4
$1.41M Buy
149,013
+31,537
+27% +$475K 1.11% 41
2018
Q3
$2.37M Buy
117,476
+34,313
+41% +$897K 1.55% 28
2018
Q2
$2.43M Buy
83,163
+5,828
+8% +$180K 1.61% 24
2018
Q1
$2.3M Buy
77,335
+25,703
+50% +$829K 1.64% 29
2017
Q4
$1.66M Sell
51,632
-1,122
-2% -$36.7K 1.43% 38
2017
Q3
$1.83M Buy
52,754
+5,401
+11% +$174K 1.45% 19
2017
Q2
$1.41M Buy
+47,353
New +$1.36M 1.25% 47

Other funds holding LJPC

Emory University's LJPC Position: Q1 2019 in Review

Emory University sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2019, closing a stake of 149,013 shares — an estimated $1.41M sold.

Emory University first reported a position in LJPC in Q2 2017 and held it in 7 quarters. The position peaked at $2.43M in Q2 2018. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.

  • Emory University reported no remaining La Jolla Pharmaceutical Company position as of Q1 2019 after selling out during the quarter.
  • Emory University sold 149,013 La Jolla Pharmaceutical Company shares in Q1 2019, an estimated $1.41M.
  • Emory University first reported a position in La Jolla Pharmaceutical Company in Q2 2017 and held it in 7 quarters.
  • Emory University's La Jolla Pharmaceutical Company position peaked at $2.43M in Q2 2018.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2019.

Based on Emory University's 13F filing for Q1 2019, filed 9 May 2019.